• All
  • Press Releases
  • News
Press Mission Bio’s Proprietary Single-Cell Genomics Platform Named One of The Scientist’s Top 10 Innovations of 2018
December 20, 2018
  As the first-ever platform aimed at predicting and preventing cancer relapse with single-cell genomics, Mission Bio’s Tapestri Platform earns highly-coveted spot on The Scientist’s annual list   Today Mission Bio, the pioneer in single-cell DNA analysis and precision genomics, announces that its flagship Tapestri® Platform, has been named one of The Scientist’s Top 10 Innovations […]
Press Mission Bio Raises $30M to Scale the First-ever Platform Aimed at Predicting and Preventing Cancer Relapse with Single-Cell Genomics
December 13, 2018
  Company will deploy funds to scale its unique targeted single-cell DNA solution for oncology and validation of CRISPR gene editing   SOUTH SAN FRANCISCO, Calif. (December 13, 2018)— Mission Bio, Inc., the pioneer in single-cell DNA analysis and precision genomics, today announced it raised $30 million in Series B funding from Agilent Technologies (NYSE: […]
News
2018 Top 10 Innovations from The Scientist
December 2, 2018 BY The Scientist
In cancer research, such analyses may allow scientists to more accurately characterize tumor heterogeneity by sampling several thousand rapidly dividing cells on an individual basis to see how they differ from one another. This is the strength of Tapestri, from Mission Bio
News
Single-Cell DNA Sequencing Platform Weaves a Way Towards Personalized Cancer Treatment
December 1, 2018
Tapestri, a sequencing platform developed by Mission Bio is the latest contender to announce itself. Tapestri has the heft of a peer-reviewed study, and the endorsement of some of the US’s largest cancer centers behind it – could Tapestri be the game-changer in DNA analysis we have been waiting for?
Press Largest Study in Single-Cell Genomics Reveals Heterogeneity Link to Cancer Relapse Using Mission Bio Tapestri® Platform
November 30, 2018
  The study findings to be presented by MD Anderson Cancer Center at 60th Annual Hematology Meeting in San Diego, CA   SOUTH SAN FRANCISCO, Calif. (November 30, 2018) Mission Bio, Inc., the pioneer in single-cell DNA analysis and precision genomics, today announced that the largest single-cell study to-date will be presented at the 60th […]
News
‘A new instruction manual for life’: Single-cell sequencing is opening up new avenues for potential treatments
November 21, 2018
Scientists, using a powerful technology called single-cell sequencing, have begun to peel apart the precise mechanisms of how individual cells operate.
News
Precision Medicine Looks beyond DNA Sequences
November 14, 2018
News
The novel platform that is accelerating cancer research
October 26, 2018
We speak to Dennis Eastburn about how high-throughput single cell DNA sequencing is being used to assess heterogeneity in cancer cell populations.
Press Mission Bio Joins NIST to Offer the Only Single-Cell DNA Analysis Platform Providing Quality Control for CRISPR Gene Editing
October 18, 2018
    SOUTH SAN FRANCISCO, Calif. (October 18, 2018) Today, Mission Bio, Inc., a pioneer in single-cell DNA analysis and precision genomics, announced its participation in the National Institute of Standards and Technology (NIST) Genome Editing Consortium, a first-of-its-kind organization established to address the need for increased confidence in genome editing technologies. Spanning academia, industry, non-profit and government, […]
Press Mission Bio Announces the First-Ever Peer-Reviewed Study Demonstrating the Power of High Throughput Single-Cell DNA Analysis
September 20, 2018
  Collaboration with MD Anderson Cancer Center shows Mission Bio’s Tapestri platform analyzes single-cell DNA at unprecedented speed and scale — advancing precision medicine and CRISPR-based research   SOUTH SAN FRANCISCO, Calif. (September 20, 2018) Mission Bio, Inc., the pioneer in high-throughput single-cell DNA analysis and precision genomics, today announced a first-of-its-kind study demonstrating its […]